유럽 q-PCR 시약 시장, 검출 유형(염료 기반 시약 및 프로브 기반 시약), 분석 유형(q-PCR 싱글플렉스 검사/분석 및 q-PCR 멀티플렉스 검사/분석), 플렉서티(염료 기반 시약 및 프로브 기반 시약), 포장 유형(키트 및 마스터 믹서), 기술(유전자 발현, 유전자 타이핑, MIRNA 분석, 사전 증폭 및 바이러스 검출), 응용 분야(연구, 진단 및 법의학), 최종 사용자(연구 및 학술 기관, 병원, 임상 연구 기관, 법의학 연구소 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) - 2029년까지의 시장 동향 및 예측.
유럽 q-PCR 시약 시장 분석 및 통찰력
유럽 q-PCR 시약 시장은 2022년에서 2029년의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 5.5%의 CAGR로 성장하고 있으며 2029년까지 4억 6,507만 달러에 도달할 것으로 예상한다고 분석합니다. 유럽 q-PCR 시약 시장 성장을 견인하는 주요 요인은 만성 질환과 전염성 질환의 증가입니다.
유럽 q-PCR 시약 시장 보고서는 시장 점유율, 새로운 개발 및 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
검출 유형(염료 기반 시약 및 프로브 기반 시약), 분석 유형(q-PCR Singleplex 검사/분석 및 q-PCR Multiplex 검사/분석), 플렉시티(염료 기반 시약 및 프로브 기반 시약), 포장 유형(키트 및 마스터 믹서), 기술(유전자 발현, 유전자 타이핑, MIRNA 분석, 사전 증폭 및 바이러스 감지), 응용 분야(연구, 진단 및 법의학), 최종 사용자(연구 및 학술 기관, 병원, 임상 연구 기관, 법의학 연구소 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) |
|
적용 국가 |
독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 스위스, 벨기에, 폴란드, 오스트리아, 아일랜드, 헝가리, 노르웨이, 러시아, 터키, 리투아니아 및 기타 유럽 |
|
시장 참여자 포함 |
Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Biotium, MiRXES Pte Ltd, GeneDireX, Inc., F. Hoffmann-La Roche Ltd, Norgen Biotek Corp, Takara Holdings Inc., Enzo Biochem Inc, Qiagen, PCR Biosystems, Quantabio, Merck KgaA, Kaneka Eurogentec SA, Promega Corporation, Solis BioDyne, Seegene Inc., Sino Biological Inc, Thermo Fisher Scientific Inc, New England Biolabs, YouSeq Ltd, Bioneer Corporation |
Market Definition
q-PCR reagents are used in the simultaneous amplification and detection/quantification of nucleic acids using the polymerase chain reaction (PCR). These reagents are used in different applications such as research, diagnosis, and forensics. They are also used for the detection of viruses, genetic stability testing, and others. The main advantage of q-PCR is that it allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range.
Europe q-PCR Reagents Market Dynamics
Drivers
- Increase in chronic diseases and communicable diseases
These diseases include cardiac diseases, cancer, and diabetes, which are the leading causes of death and disability in Europe.
q-PCR reagents are essential for the diagnosis of chronic diseases such as human Immuno Deficiency Virus (HIV) and malaria. Both conditions have non-specific symptoms. The q-PCR kits and mixers contain all the necessary PCR reagents for rapid, sensitive, and reproducible real-time detection of HIV and other diseases using highly specific primer pairs.
- Increase in the geriatric population
The geriatric population is susceptible to chronic and malignant diseases. The non-specific antibodies are more in the elderly population. The diagnosis through q-PCR reagents is important for the elderly population as it provides early diagnosis, which is crucial to prevent the extensive spread of the disease since the test is non-invasive and it aids in determining antigen detection in chronic infectious diseases.
There were approx.—1 million persons aged 65 years or over in Europe in 2022. The number of older persons is projected to double to 1.5 billion in 2050. Since the senior population is increasing hence the need for q-PCR reagents will also increase.
Opportunities
- The rise in government funding for healthcare
The government, federations, and major market players are creating opportunities across Europe. These initiatives by the players and government are helping the users reach out to take advantage of the policies made for low-income and developing nations and making them aware of preventable diseases if diagnosed earlier.
- The rise in healthcare expenditure
Increasing healthcare expenditure and infrastructure can help the patient take hassle-free advanced treatment to receive better diagnoses, procedures, and fast recovery. The spending on health is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and sources, including health insurance and activities by non-governmental organizations.
An increase in healthcare expenditure and maintaining a good infrastructure has allowed end-users to adopt advanced q-PCR devices. An increase in the healthcare infrastructure is also impacted by to increase in the adoption of advanced q-PCR devices in hospitals and diagnostic centers for providing detailed imaging examinations for better diagnosis. Improving infrastructure development activities for the installation of new advanced technology-based products for diagnostic procedures and more healthcare expenditure are the factors changing R&D models in research-based for the adoption of the latest product in the hospital and providing better diagnosis results.
Restraints/Challenges
- High Cost of product
Modern technology reagents and devices lead to the high cost of treatment. The reagents and kits require a huge cost for the development process. The supply of raw materials, the regulatory process, and others also add up to the cost of the products. Additionally, the process is time-consuming as it needs sufficient time to fully mature before bringing into the market for use.
Furthermore, any changes that must be re-verified will impact time, and the growing advancements need an effective investment for successful operations along with a project risk management plan. The establishment of R&D for conducting research entails high costs, which in turn leads to expensive point-of-care devices. Thus, this factor is acting as a major restrain for the market
- Advancement in the field of genomics
The advancement in the field of the Human Genome or genomics by discovering sequences in the 3 billion letters of the genetic code made it possible for scientists to study and understand the factors that played a role in disease development. Also, in recent years many new prevention and treatment strategies have been discovered, which have decreased the market of q-PCR reagents as this genomics provides better results in a short period with lesser complications.
- Operational barriers faced in conducting diagnostic tests
Recent advances in the field of diagnostics may be related to kits, instruments, reagents, control, or any other, and it is not easy to adapt to the new advancement and techniques of healthcare professionals. To make structural decisions and précised results in diagnostics, organizations need to conduct training sessions for healthcare professionals to overcome and avoid errors in diagnosis.
Rural, developing, and low-income countries in the region do not have enough infrastructures to maintain the new kits and for sample storage as well. This is because of the limited supply of electricity and lack and education and awareness among healthcare professionals in the handling of new kits and reagents. This leads to errors in the diagnosis results and can lead to certain deaths, and can become a threat to the carrier of the individual performing the test.
성비와 의료 전문가의 연령이 급증하여 많은 지역의 진단 인력에 영향을 미치고 있습니다. 또한 감염성 질환 환자를 다루는 직업과 관련된 위험이나 윤리적 문제로 인해 검사와 진단을 수행하는 데 장벽이 되고 있습니다.
진단 검사 수행과 관련된 이러한 장벽은 인구의 삶에 영향을 미칠 수 있으며, 이는 저소득 국가에서 극복하기 가장 어려운 부분 중 하나입니다. 따라서 이는 진단 커뮤니티에 영향을 미치고 유럽 q-PCR 시약 시장에 도전으로 작용하고 있습니다.
유럽 q-PCR 시약 시장 범위
유럽 q-PCR 시약 시장은 검출 유형, 분석 유형, 플렉시티, 패키징 유형, 응용 분야, 기술, 최종 사용자 및 유통 채널을 기준으로 분류됩니다. 이러한 세그먼트 간의 성장은 산업의 주요 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 분야를 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
감지 유형
- 염료 기반 시약
- 프로브 기반 시약
검출 유형을 기준으로 유럽 q-PCR 시약 시장은 염료 기반 시약과 프로브 기반 시약으로 분류됩니다.
검정 유형
- q-PCR 싱글플렉스 검사/분석
- q-PCR 멀티플렉스 검사/분석
검사 유형을 기준으로 유럽 q-PCR 시약 시장은 q-PCR 싱글플렉스 검사/검사와 q-PCR 멀티플렉스 검사/검사로 분류됩니다.
플렉시티
- 염료 기반 시약
- 프로브 기반 시약
유럽 q-PCR 시약 시장은 유연성을 기준으로 염료 기반 시약과 프로브 기반 시약으로 분류됩니다.
포장 유형
- 키트
- 마스터 믹스
유럽 q-PCR 시약 시장은 포장 유형에 따라 키트와 마스터 믹스로 분류됩니다.
기술
- 유전자 발현
- 유전자 타이핑
- MIRNA 분석
- 사전 증폭
- 바이러스 감지
유럽 q-PCR 시약 시장은 기술을 기준으로 유전자 발현, 유전자 타이핑, MIRNA 분석, 사전 증폭 및 바이러스 검출로 분류됩니다.
애플리케이션
- 진단
- 연구
- 법의학
유럽 q-PCR 시약 시장은 응용 분야를 기준으로 진단, 연구, 법의학으로 구분됩니다.
최종 사용자
- 병원 및 진단 센터
- 법의학 연구실
- 연구 및 학술 기관
- 임상연구기관
- 기타
유럽 q-PCR 시약 시장은 최종 사용자를 기준으로 병원 및 진단 센터, 법의학 연구소, 연구 및 학술 기관, 임상 연구 기관 등으로 구분됩니다.
유통 채널
- 직접 입찰
- 제3자 유통업체
- 기타
유럽 q-PCR 시약 시장은 유통 채널을 기준으로 직접 입찰, 제3자 유통업체 및 기타로 구분됩니다.
유럽 q-PCR 시약 시장 지역 분석/통찰력
유럽 q-PCR 시약 시장은 검출 유형, 분석 유형, 복잡성, 포장 유형, 응용 분야, 기술, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.
유럽 q-PCR 시약 시장의 국가는 독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 스위스, 벨기에, 폴란드, 오스트리아, 아일랜드, 헝가리, 노르웨이, 러시아, 터키, 리투아니아 및 기타 유럽 국가입니다.
독일은 시장 참여자들의 강력한 입지와 HIV 등 전염병의 유병률 증가로 인해 시장 점유율과 시장 수익 면에서 유럽 q-PCR 시약 시장을 지배하고 있습니다.
보고서의 국가 섹션은 또한 시장의 현재 및 미래 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제 변경 사항을 제공합니다. 데이터 포인트 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석 및 사례 연구는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE Q-PCR REAGENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 DETECTION TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
5 REGULATION
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN CHRONIC DISEASES AND COMMUNICABLE DISEASES
6.1.2 INCREASE IN GERIATRIC POPULATION
6.1.3 INCREASE IN EARLY DIAGNOSIS RATE
6.1.4 INCREASE IN ADVANCED TECHNOLOGY
6.2 RESTRAINTS
6.2.1 HIGH COST OF PRODUCT
6.2.2 ADVANCEMENT IN FIELD OF GENOMICS
6.3 OPPORTUNITIES
6.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.4 CHALLENGES
6.4.1 LACK OF SKILLED WORKFORCE
6.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
7 EUROPE Q-PCR REAGENTS MARKET, BY DETECTION TYPE
7.1 OVERVIEW
7.2 DYE-BASED REAGENTS
7.2.1 MASTER MIX
7.2.2 PRIMERS
7.2.3 DNA TEMPLATE
7.3 PROBE-BASED REAGENTS
7.3.1 MASTER MIX
7.3.2 PRIMERS
7.3.3 DNA TEMPLATE
8 EUROPE Q-PCR REAGENTS MARKET, BY ASSAY TYPE
8.1 OVERVIEW
8.2 QPCR SINGLEPLEX TEST/ASSAY
8.3 QPCR MULTIPLEX TEST/ASSAY
9 EUROPE Q-PCR REAGENTS MARKET, BY PLEXITY
9.1 OVERVIEW
9.2 DYE-BASED REAGENTS
9.2.1 SINGLEPLEX
9.2.2 MULTIPLEX
9.3 PROBE-BASED REAGENTS
9.3.1 SINGLEPLEX
9.3.2 MULTIPLEX
10 EUROPE Q-PCR REAGENTS MARKET, BY PACKAGING TYPE
10.1 OVERVIEW
10.2 KITS
10.3 MASTER MIXERS
11 EUROPE Q-PCR REAGENTS MARKET, BY TECHNOLOGY
11.1 OVERVIEW
11.2 GENE EXPRESSION
11.3 GENE TYPING
11.4 MIRNA ANALYSIS
11.5 PRE-AMPLIFICATION
11.6 VIRUS DETECTION
12 EUROPE Q-PCR REAGENTS MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 RESEARCH
12.3 DIAGNOSTICS
12.4 FORENSIC
13 EUROPE Q-PCR REAGENTS MARKET, BY END USER
13.1 OVERVIEW
13.2 RESEARCH & ACADEMIC INSTITUTE
13.3 HOSPITAL AND DIAGNOSTIC CENTERS
13.4 CLINICAL RESEARCH ORGANIZATION
13.5 FORENSIC LABORATORIES
13.6 OTHERS
14 EUROPE Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 THIRD PARTY DISTRIBUTORS
14.4 OTHERS
15 EUROPE Q-PCR REAGENTS MARKET, BY COUNTRY
15.1 EUROPE
15.1.1 GERMANY
15.1.2 U.K.
15.1.3 FRANCE
15.1.4 ITALY
15.1.5 SPAIN
15.1.6 NETHERLANDS
15.1.7 SWITZERLAND
15.1.8 BELGIUM
15.1.9 POLAND
15.1.10 AUSTRIA
15.1.11 IRELAND
15.1.12 HUNGARY
15.1.13 NORWAY
15.1.14 RUSSIA
15.1.15 TURKEY
15.1.16 LITHUANIA
15.1.17 REST OF EUROPE
16 EUROPE Q-PCR REAGENTS MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 F. HOFFMANN-LA ROCHE LTD
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 PRODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENT
18.2 MERCK KGAA
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.2.4.1 PARTNERSHIP
18.2.4.2 NEW LABORATORY FACILITY
18.2.5 NEW DISTRIBUTION CENTER
18.3 THERMO FISHER SCIENTIFIC INC
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENTS
18.3.4.1 ACQUISITION
18.3.4.2 PRODUCT LAUNCH
18.4 AGILENT TECHNOLOGIES, INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.4.4.1 DISTRIBUTION AGREEMENT
18.4.4.2 PRODUCT LAUNCH
18.5 SEEGENE INC.
18.5.1 COMPANY SNAPSHOT
18.5.2 PRODUCT PORTFOLIO
18.5.3 RECENT DEVELOPMENT
18.5.3.1 PRODUCT SUPPLY
18.6 BIONEER CORPORATION
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.6.3.1 AGREEMENT
18.7 BIO-RAD LABORATORIES, INC.
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.7.4.1 PARTNERSHIP
18.7.5 AWARD
18.8 BIOTIUM
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 ENZO BIOCHEM INC
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENT
18.1 GENEDIREX, INC
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 KANEKA EUROGENTEC S.A
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.11.4.1 PRODUCT LAUNCH
18.12 MIRXES PTE LTD
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 NORGEN BIOTEK CORP
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 NEW ENGLAND BIOLABS
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.14.3.1 AQUISITION
18.14.4 PRODUCT LAUNCH
18.14.5 SUBSIDIARY
18.15 PCR BIOSYSTEMS
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 PROMEGA CORPORATION
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.16.3.1 R&D FACILITY
18.17 QIAGEN
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.17.4.1 NEW FACILITY
18.17.4.2 ACQUISITION
18.18 QUANTABIO
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.18.3.1 CONFERENCE
18.18.3.2 PRODUCT LAUNCH
18.19 SINO BIOLOGICAL INC.
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.19.3.1 NEW FACILITY
18.2 SOLIS BIODYNE
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.20.3.1 R&D FACILITY
18.21 TAKARA HOLDINGS INC
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.21.4.1 MANUFACTURING UNIT
18.21.5 ISO CERTIFICATION
18.22 YOUSEQ LTD
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENT
18.22.3.1 ISO CERTIFICATION
19 QUESTIONNAIRE
20 RELATED REPORTS
표 목록
TABLE 1 EUROPE Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 2 EUROPE DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 3 EUROPE PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 4 EUROPE Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 5 EUROPE Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 6 EUROPE DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 7 EUROPE PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 8 EUROPE Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 9 EUROPE Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 10 EUROPE Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 12 EUROPE Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 13 EUROPE Q-PCR REAGENTS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 14 GERMANY Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 15 GERMANY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 16 GERMANY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 GERMANY Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 18 GERMANY Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 19 GERMANY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 20 GERMANY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 21 GERMANY Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 22 GERMANY Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 23 GERMANY Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 GERMANY Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 25 GERMANY Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 26 U.K. Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 27 U.K. DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 28 U.K. PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 29 U.K. Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 30 U.K. Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 31 U.K. DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 32 U.K. PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 33 U.K. Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 34 U.K. Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 35 U.K. Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 U.K. Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 37 U.K. Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 38 FRANCE Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 39 FRANCE DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 40 FRANCE PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 FRANCE Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 42 FRANCE Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 43 FRANCE DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 44 FRANCE PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 45 FRANCE Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 46 FRANCE Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 47 FRANCE Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 48 FRANCE Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 FRANCE Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 50 ITALY Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 51 ITALY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 52 ITALY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 ITALY Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 54 ITALY Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 55 ITALY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 56 ITALY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 57 ITALY Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 58 ITALY Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 59 ITALY Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 ITALY Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 ITALY Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 62 SPAIN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 63 SPAIN DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 SPAIN PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 SPAIN Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 66 SPAIN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 67 SPAIN DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 68 SPAIN PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 69 SPAIN Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 70 SPAIN Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 71 SPAIN Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 72 SPAIN Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 73 SPAIN Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 74 NETHERLANDS Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 75 NETHERLANDS DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 76 NETHERLANDS PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 77 NETHERLANDS Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 78 NETHERLANDS Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 79 NETHERLANDS DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 80 NETHERLANDS PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 81 NETHERLANDS Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 82 NETHERLANDS Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 83 NETHERLANDS Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 NETHERLANDS Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 NETHERLANDS Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 SWITZERLAND Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 87 SWITZERLAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 88 SWITZERLAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 89 SWITZERLAND Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 90 SWITZERLAND Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 91 SWITZERLAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 92 SWITZERLAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 93 SWITZERLAND Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 94 SWITZERLAND Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 95 SWITZERLAND Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 96 SWITZERLAND Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 97 SWITZERLAND Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 98 BELGIUM Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 99 BELGIUM DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 100 BELGIUM PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 101 BELGIUM Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 102 BELGIUM Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 103 BELGIUM DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 104 BELGIUM PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 105 BELGIUM Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 106 BELGIUM Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 107 BELGIUM Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 108 BELGIUM Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 109 BELGIUM Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 110 POLAND Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 111 POLAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 112 POLAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 113 POLAND Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 114 POLAND Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 115 POLAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 116 POLAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 117 POLAND Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 118 POLAND Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 119 POLAND Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 120 POLAND Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 121 POLAND Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 122 AUSTRIA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 123 AUSTRIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 124 AUSTRIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 125 AUSTRIA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 126 AUSTRIA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 127 AUSTRIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 128 AUSTRIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 129 AUSTRIA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 130 AUSTRIA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 131 AUSTRIA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 132 AUSTRIA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 133 AUSTRIA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 134 IRELAND Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 135 IRELAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 136 IRELAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 137 IRELAND Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 138 IRELAND Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 139 IRELAND DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 140 IRELAND PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 141 IRELAND Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 142 IRELAND Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 143 IRELAND Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 144 IRELAND Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 145 IRELAND Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 146 HUNGARY Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 147 HUNGARY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 148 HUNGARY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 149 HUNGARY Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 150 HUNGARY Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 151 HUNGARY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 152 HUNGARY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 153 HUNGARY Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 154 HUNGARY Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 155 HUNGARY Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 156 HUNGARY Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 157 HUNGARY Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 158 NORWAY Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 159 NORWAY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 160 NORWAY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 161 NORWAY Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 162 NORWAY Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 163 NORWAY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 164 NORWAY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 165 NORWAY Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 166 NORWAY Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 167 NORWAY Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 168 NORWAY Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 169 NORWAY Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 170 RUSSIA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 171 RUSSIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 172 RUSSIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 173 RUSSIA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 174 RUSSIA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 175 RUSSIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 176 RUSSIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 177 RUSSIA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 178 RUSSIA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 179 RUSSIA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 180 RUSSIA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 181 RUSSIA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 182 TURKEY Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 183 TURKEY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 184 TURKEY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 185 TURKEY Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 186 TURKEY Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 187 TURKEY DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 188 TURKEY PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 189 TURKEY Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 190 TURKEY Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 191 TURKEY Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 192 TURKEY Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 193 TURKEY Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 194 LITHUANIA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 195 LITHUANIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 196 LITHUANIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 197 LITHUANIA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 198 LITHUANIA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 199 LITHUANIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 200 LITHUANIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 201 LITHUANIA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 202 LITHUANIA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 203 LITHUANIA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 204 LITHUANIA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 205 LITHUANIA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 206 REST OF EUROPE Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 EUROPE Q-PCR REAGENTS MARKET : SEGMENTATION
FIGURE 2 EUROPE Q-PCR REAGENTS MARKET : DATA TRIANGULATION
FIGURE 3 EUROPE Q-PCR REAGENTS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE Q-PCR REAGENTS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE Q-PCR REAGENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Q-PCR REAGENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE Q-PCR REAGENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE Q-PCR REAGENTS MARKET: APPLICATION COVERAGE GRID
FIGURE 9 EUROPE Q-PCR REAGENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE Q-PCR REAGENTS MARKET: SEGMENTATION
FIGURE 11 INCREASE IN DEMAND FOR Q-PCR REAGENTS IS EXPECTED TO DRIVE THE EUROPE Q-PCR REAGENTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 DYE-BASED REAGENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE Q-PCR REAGENTS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINT, OPPORTUNITY AND CHALLENGES OF EUROPE Q-PCR REAGENTS MARKET
FIGURE 14 EUROPE Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2021
FIGURE 15 EUROPE Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2020-2029 (USD MILLION)
FIGURE 16 EUROPE Q-PCR REAGENTS MARKET: BY DETECTION TYPE, CAGR (2022-2029)
FIGURE 17 EUROPE Q-PCR REAGENTS MARKET: BY DETECTION TYPE, LIFELINE CURVE
FIGURE 18 EUROPE Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2021
FIGURE 19 EUROPE Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2020-2029 (USD MILLION)
FIGURE 20 EUROPE Q-PCR REAGENTS MARKET: BY ASSAY TYPE, CAGR (2022-2029)
FIGURE 21 EUROPE Q-PCR REAGENTS MARKET: BY ASSAY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE Q-PCR REAGENTS MARKET: BY PLEXITY, 2021
FIGURE 23 EUROPE Q-PCR REAGENTS MARKET: BY PLEXITY, 2020-2029 (USD MILLION)
FIGURE 24 EUROPE Q-PCR REAGENTS MARKET: BY PLEXITY, CAGR (2022-2029)
FIGURE 25 EUROPE Q-PCR REAGENTS MARKET: BY PLEXITY, LIFELINE CURVE
FIGURE 26 EUROPE Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2021
FIGURE 27 EUROPE Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2020-2029 (USD MILLION)
FIGURE 28 EUROPE Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, CAGR (2022-2029)
FIGURE 29 EUROPE Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, LIFELINE CURVE
FIGURE 30 EUROPE Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2021
FIGURE 31 EUROPE Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2020-2029 (USD MILLION)
FIGURE 32 EUROPE Q-PCR REAGENTS MARKET: BY TECHNOLOGY, CAGR (2022-2029)
FIGURE 33 EUROPE Q-PCR REAGENTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 34 EUROPE Q-PCR REAGENTS MARKET: BY APPLICATION, 2021
FIGURE 35 EUROPE Q-PCR REAGENTS MARKET: BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 36 EUROPE Q-PCR REAGENTS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 37 EUROPE Q-PCR REAGENTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 EUROPE Q-PCR REAGENTS MARKET: BY END USER, 2021
FIGURE 39 EUROPE Q-PCR REAGENTS MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 40 EUROPE Q-PCR REAGENTS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 41 EUROPE Q-PCR REAGENTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 EUROPE Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 43 EUROPE Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 44 EUROPE Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 45 EUROPE Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 EUROPE Q-PCR REAGENTS MARKET: SNAPSHOT (2021)
FIGURE 47 EUROPE Q-PCR REAGENTS MARKET: BY COUNTRY (2021)
FIGURE 48 EUROPE Q-PCR REAGENTS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 49 EUROPE Q-PCR REAGENTS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 50 EUROPE Q-PCR REAGENTS MARKET: BY DETECTION TYPE (2022-2029)
FIGURE 51 EUROPE Q-PCR REAGENTS MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
